ActiveSight and CHDI Leverage Fragment-Based Lead Discovery for Huntington Disease Therapies
9/18/2007 8:45:43 AM
More...
|
ActiveSight Signs Multi-Target Crystallography Service Agreement With Lexicon Pharmaceuticals, Inc. (LEXG)
1/5/2007 11:56:57 AM
More...
|
ActiveSight Launches Fragment Screening Service And Four New Crystal Targets For Structure Based Drug Design: FAK, Caspase 3, PTP-1B, And DPP-4
2/28/2006 11:43:03 AM
More...
|
QIAGEN (QGENF) And ActiveSight Sign Co-Marketing Agreement Targeting Protein Crystallography
2/22/2006 10:58:40 AM
More...
|
ActiveSight Signs Protein Crystallography Agreement With Novo Nordisk A/S (NVO)
1/23/2006 11:41:54 AM
More...
|
ActiveSight To Provide Crystallography Services To Inpharmatica
11/17/2005 11:13:03 AM
More...
|
ActiveSight To Provide Protein Crystallography To Ambit Biosciences Corporation
11/1/2005 12:31:08 PM
More...
|
ActiveSight Introduces Protein Crystal Targets For Oncology, Cardiovascular, And Anti-Infective Research
10/19/2005 5:13:04 PM
More...
|
ActiveSight To Provide Protein Crystallography To Serenex
10/19/2005 5:12:49 PM
More...
|
ActiveSight Release: Fructose-1,6-bisphosphatase Diabetes Target Available For Structure Based Drug Design
10/19/2005 5:12:34 PM
More...
|
|